David Benjamin Turitz Cox

Dr. Cox is a highly respected physician-scientist with his research focus on genome editing, characterization and mammalian applications of CRISPR systems, as well as exploring genome editing tools at a molecular level. Dr. Cox serves as a Scientific Advisor for his expertise in gene editing technology and its cell therapy applications.

Dr. Cox received his bachelor’s degree in Biology with honors at Stanford University. Then he was admitted to the Harvard-MIT MD-PhD Program, which is specifically designed for training the next-generation of premier and diverse physician-scientist leaders. He obtained his Ph.D. in Biology from MIT, during which he discovered a gene-editing technology using the CRISPR-Cas 13 system under the supervision of Professor Zhang Feng, a leading figure in the gene-editing. This RNA editing platform allows efficient and precise RNA correction in mammalian cells, which holds great potential in treating genetic diseases. This novel technology was runner-up for Science’s 2017 Breakthrough of the Year and was selected as one of the top technical advances of 2017 by The Scientist. He has filed more than seven patent applications in United States and around the world.

Dr. Cox received his M.D. from Harvard Medical School and was awarded his research and clinical training fellowship in Hematology/Oncology in the Stanford Translational Investigator Program (TIP). At present, he is a physician at Stanford University.